Vedanta Biosciences, Inc
vedantabio.com
Actively hiring
Microbiome
Biotechnology
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$183.1M
3 rounds on record
Latest round
$60M
Venture round · Aug 2026 · 1 mo ago
Team
201-500
employees, estimated range
Backers
1
AMR Action Fund
The money's age
Fresh money
1 months since the last round · not hiring
Momentum
35/100
in the news, fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Aug 2026 | $60M | — | morningstar.com |
| Venture round | May 2023 | $106.5M | — | Pulse 2.0 |
| Series C | Sep 2019 | $16.6M | — | PE Hub |
Backed byfrom the funds' portfolios and accelerator catalogs
AMR Action Fund Similar startupsby what they do, their industry and backers
BiomeBank is a clinical stage biotechnology company with a mission to treat our microbiome and prevent disease by restoring gut microbial…
P.Happi® is a daily serum that supports the intimate microbiome by protecting from bad bacteria and supporting the natural flora. The first…
ZBiotics engineers probiotic bacteria for consumer products, starting with a drink that breaks down the alcohol by-product behind…
BIOHM Health has probiotic supplements, super greens powders, and colon cleanse products to heal leaky gut & to utilize your microbiome of…
Our unique, next-generation microbiome modulator for optimized gut health for the animal protein industry.
Bloom Nutrition provides health and wellness supplements for women, with high quality ingredients to support energy, gut health and hormone…
News
Vedanta Biosciences Secures $60 Million in Funding and Strengthens Leadership Team Ahead of Pivotal Phase 3 Data
Read more
Report
Vedanta Biosciences Showcases Innovative Work on its Microbiome-based Therapeutics at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) 2026 Global Congress
CAMBRIDGE, Mass., April 09, 2026--Vedanta Biosciences, a late clinical-stage biopharmaceutical company developing microbiome-based oral therapies for gastrointestinal diseases, today announced a poster presentation related to the company's work on VE303,
Read more
Report
Vedanta Biosciences Showcases Innovative Work on its Microbiome-based Therapeutics at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) 2026 Global ...
Read more
Report
Hello world!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing! The post Hello world! appeared first on Vedanta Biosciences, Inc.
Read more
Report
Pro access
Upgrade to see all 10 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.